Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Cosmo Technologies Ltd
*MAILING ADDRESS
Riverside II, Sir John Rogerson's Quay
*CITY
Dublin 2
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
*EMAIL ADDRESS
n.hall@frkelly.com
LEGAL ENTITY INFORMATION
TYPE
company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED
Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Contrast media for use with medical equipment or in medical imaging; Diagnostic agents and reagents for medical use; Diagnostic preparations;
Pharmaceutical preparations and substances; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Non-prescription medicines;
Gastroenteric preparations; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and
other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use
with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of
gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations
containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and
surgical purposes; methylene blue or dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative
colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology,
renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for
maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; anti-nauseants; antiemetic preparations; antibiotic preparations; pharmaceutical
preparations for the treatment or prevention of travellers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
044
*IDENTIFICATION
Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and
therapeutic properties of pharmaceuticals.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88820915
Filing Date:03/04/020
To the Commissioner for Trademarks:
MARK: MMX (Standard Characters, see mark)
The literal element of the mark consists of MMX. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Cosmo Technologies Ltd, a company organized under the laws of Ireland, having an address of
Riverside II, Sir John Rogerson's Quay
Dublin 2
Ireland
n.hall@frkelly.com
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Contrast media for use with medical equipment or in medical imaging; Diagnostic agents and reagents for medical use; Diagnostic preparations; Pharmaceutical
preparations and substances; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Non-prescription medicines; Gastroenteric
preparations; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions
in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with
gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of
gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations
containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and
surgical purposes; methylene blue or dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative
colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology,
renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for
maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; anti-nauseants; antiemetic preparations; antibiotic preparations; pharmaceutical
preparations for the treatment or prevention of travellers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Egypt application number 345302, filed 11/20/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 044: Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of
pharmaceuticals.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on European Union Trademark - EUTM application number 18205433, filed 03/04/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
The owner's/holder's proposed attorney information: Joerg-Uwe Szipl. Joerg-Uwe Szipl of Merchant & Gould, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is
located at
PO Box 2910
Minneapolis, Minnesota 55405
United States
612-332-5300(phone)
6123329081(fax)
DOCKMPLS@merchantgould.com
The docket/reference number is 12343.26US01.
Joerg-Uwe Szipl submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant hereby appoints Joerg-Uwe Szipl of Merchant & Gould
PO Box 2910
Minneapolis Minnesota 55405
United States
612-332-5300(phone)
6123329081(fax)
DOCKMPLS@merchantgould.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Joerg-Uwe Szipl/ Date: 03/04/2020
Signatory's Name: Joerg-Uwe Szipl
Signatory's Position: Attorney of Record, VA Bar Member
Payment Sale Number: 88820915
Payment Accounting Date: 03/04/2020
Serial Number: 88820915
Internet Transmission Date: Wed Mar 04 15:40:13 ET 2020
TEAS Stamp: USPTO/BAS-XX.XX.XXX.X-202003041540137489
35-88820915-710a8716e489d808acdfdca8fe91
b712f5714b2115b904cd9d892f24eaf0fbc99a-C
C-40120401-20200304152349705778